Cargando…
LV wall motion assessment during regadenoson vasodilator stress CMR
Autores principales: | Jesinger, Michael, Sorrell, Vincent L, Leung, Steve W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032349/ http://dx.doi.org/10.1186/1532-429X-18-S1-P81 |
Ejemplares similares
-
Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015) -
Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015) -
Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011) -
Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014) -
CMR of LV non-compaction cardiomyopathy: association of clinical presentation and prognosis with cardiac phenotype
por: Syed, Mushabbar A, et al.
Publicado: (2011)